Endevica Bio
Endevica Bio is a biotechnology company that develops drugs to treat cachexia.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Endevica Bio Information
Geographic Data
Address:
City: Columbia
State: Missouri
Zip:
Country: United States
Financial Info
Stage:
grant
Raised Last:
$2M
Raised Total:$4M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Endevica Bio create best-in-class peptide drug candidates with better safety and efficacy properties than other drugs in the same class. Endevica’s technology platform, protected by a family of patents and pending applications, allows for the modification of peptides to perform with improved half-life, oral activity, and the ability to cross the blood-brain barrier.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2016 | Grant | 1 | $2.3M |
National Cancer Institute National Cancer Institute |
1/2023 | Series B | $10M | 6/2016 | Series A | 1 | $1.7M |
Centennial Investors Centennial Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
